Primary Site >> Esophagus Cancer
Gene >> CRP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Identification of acute-phase proteins (APP) in circulating immune complexes (CIC) in esophageal cancer patients' sera. PMID: 8816857 |
Ref: Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma. PMID: 9486779 Ref: Prediction for the development of postoperative infections in the operation of esophageal cancer compared with gastric surgery. PMID: 9810782 |
Ref: Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. PMID: 11574097 |
Ref: Prognostic value of preoperative serum immunosuppressive acidic protein in patients with esophageal squamous cell carcinoma. PMID: 12823207 Ref: Influences of thoracic duct blockage on early enteral nutrition for patients who underwent esophageal cancer surgery. PMID: 12892455 Ref: Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. PMID: 12894012 Ref: Levels of some acute-phase proteins in the serum of patients with cancer during radiotherapy. PMID: 14519962 |
Ref: Appraisal of the simultaneous right-thoracic and abdominal approach with intrathoracic reconstruction after esophageal resection for patients with intrathoracic esophageal cancer. PMID: 15532813 |
Ref: Serum procalcitonin levels are elevated in esophageal cancer patients with postoperative infectious complications. PMID: 15818038 Ref: Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. PMID: 16045574 Ref: Urinary protein analysis in pre- and postoperative cancer patients. PMID: 16302210 |
Ref: Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. PMID: 16550581 |
Ref: Increased serum vascular endothelial growth factor following major surgical injury. PMID: 17625371 |
Ref: Respiratory insufficiency related to COPD accelerates systemic inflammation, under-nutrition, and angiogenesis in esophageal malignancies. PMID: 18438346 |
Ref: Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy. PMID: 19195729 Ref: [Are leukocytes and CRP early indicators for anastomotic leakage after esophageal resection?]. PMID: 19242888 Ref: C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer. PMID: 19801321 |
Ref: Association of C-reactive protein levels and long-term survival after neoadjuvant therapy and esophagectomy for esophageal cancer. PMID: 19937473 Ref: The CRP 1846T/T genotype is associated with a poor prognosis in patients with non-small cell lung cancer. PMID: 20686879 Ref: [Effect of minimally invasive Ivor-Lewis esophagectomy on acute phase responses in patients with esophageal carcinoma]. PMID: 21223696 Ref: [Early prediction of treatment response by serum CRP levels in patients with advanced esophageal cancer who underwent definitive chemoradiotherapy]. PMID: 21224533 |
Ref: Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer. PMID: 20981494 Ref: Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer. PMID: 21031427 Ref: Influence of neutrophil elastase inhibitor on the postoperative course in patients with esophageal cancer after transthoracic esophagectomy. PMID: 22086688 |
Ref: Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus). PMID: 22467322 Ref: Interleukin 6 and C-reactive protein in esophageal cancer. PMID: 22609487 Ref: Risk factors for postoperative respiratory complications following esophageal cancer resection. PMID: 22741016 Ref: Fuzzy logic-based prognostic score for outcome prediction in esophageal cancer. PMID: 22875252 |
Ref: A CRP genetic polymorphism associated with the tumoral expression of CRP in esophageal cancer. PMID: 22911253 Ref: Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma. PMID: 23212764 Ref: [Five cases of severe radiation pneumonitis after chemoradiotherapy for esophageal cancer]. PMID: 24394039 Ref: Time course of serum C-reactive protein levels during induction chemoradiotherapy and its correlation with treatment response and survival in patients with advanced esophageal squamous cell carcinoma. PMID: 24649211 |
Ref: Immunological changes after minimally invasive or conventional esophageal resection for cancer: a randomized trial. PMID: 24101016 Ref: Randomized study of antiinflammatory and immune-modulatory effects of enteral immunonutrition during concurrent chemoradiotherapy for esophageal cancer. PMID: 24274379 Ref: The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment. PMID: 24975677 Ref: Prognostic value of C-reactive protein in esophageal cancer: a meta-analysis. PMID: 25338987 |
Ref: Randomized Phase II Study of the Anti-inflammatory Effect of Ghrelin During the Postoperative Period of Esophagectomy. PMID: 25361222 Ref: Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis. PMID: 25653533 Ref: Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer. PMID: 25808437 Ref: Correlation Between Intense Postoperative Inflammatory Response and Survival of Esophageal Cancer Patients Who Underwent Transthoracic Esophagectomy. PMID: 25893412 Ref: The combination of preoperative serum C-reactive protein and carcinoembryonic antigen is a useful prognostic factor in patients with esophageal squamous cell carcinoma: a combined ROC analysis. PMID: 25914550 Ref: Thrombocytosis and Raised CRP Levels Predicts Advanced Stage in Esophageal Carcinoma. PMID: 26202142 |
Ref: Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer. PMID: 25515972 Ref: The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer. PMID: 27041792 Ref: Association between the inflammatory biomarker, C-reactive protein, and the response to radiochemotherapy in patients with esophageal cancer. PMID: 27073683 Ref: Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer. PMID: 27401305 Ref: The Influence of Neoadjuvant Chemotherapy with Docetaxel, Nedaplatin and 5-Fluorouracil After Esophagectomy. PMID: 27793947 Ref: Prognostic Significance of Inflammatory and Nutritional Parameters in Patients with Esophageal Cancer. PMID: 27919983 Ref: Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer. PMID: 28339508 |
Ref: Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy. PMID: 27839896 Ref: C-Reactive Protein Indicates Early Stage of Postoperative Infectious Complications in Patients Following Minimally Invasive Esophagectomy. PMID: 27878351 Ref: Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer. PMID: 28120093 Ref: Effects of a preoperative immune-modulating diet in patients with esophageal cancer: a prospective parallel group randomized study. PMID: 28283752 Ref: Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303). PMID: 28717855 Ref: C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer. PMID: 28881893 Ref: Prediction of postoperative inflammatory complications after esophageal cancer surgery based on early changes in the C-reactive protein level in patients who received perioperative steroid therapy and enhanced recovery after surgery care: a retrospective PMID: 29202716 Ref: High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy. PMID: 29245945 Ref: C-reactive protein for the early prediction of anastomotic leak after esophagectomy in both neoadjuvant and non-neoadjuvant therapy case: a propensity score matching analysis. PMID: 29268376 |
Ref: Predictive factors for major postoperative complications related to gastric conduit reconstruction in thoracoscopic esophagectomy for esophageal cancer: a case control study. PMID: 29510754 Ref: Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis. PMID: 29644466 Ref: Relationship Between Visceral Obesity and Postoperative Inflammatory Response Following Minimally Invasive Esophagectomy. PMID: 29766228 Ref: The effects of the herbal medicine Daikenchuto (TJ-100) after esophageal cancer resection, open-label, randomized controlled trial. PMID: 29892933 Ref: Surgical team proficiency in minimally invasive esophagectomy is related to case volume and improves patient outcomes. PMID: 29892937 Ref: Meaning of C-reactive protein around esophagectomy for cStage III esophageal cancer. PMID: 30167922 |